Beranda › Neuropati Sensorik dan Otonom Herediter
Uji klinis Neuropati Sensorik dan Otonom Herediter yang merekrut di AS
21 studi untuk Neuropati Sensorik dan Otonom Herediter merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- San Antonio, TX7 studi
- Arlington, VA7 studi
- Nashville, TN6 studi
- Boston, MA6 studi
- New York City, NY6 studi
- Houston, TX5 studi
- Philadelphia, PA5 studi
- Washington, DC4 studi
- Ann Arbor, MI4 studi
- Portland, OR4 studi
- Pittsburgh, PA4 studi
- Aurora, CO3 studi
- Los Angeles, CA3 studi
- San Francisco, CA3 studi
- Charlotte, NC3 studi
- Cincinnati, OH3 studi
- Denver, CO3 studi
Berdasarkan negara bagian
- Arizona3 studi
- California9 studi
- Colorado7 studi
- Distrik Columbia3 studi
- Florida7 studi
- Maryland5 studi
- Massachusetts6 studi
- Michigan5 studi
- Minnesota3 studi
- Missouri3 studi
- New York8 studi
- North Carolina5 studi
- Ohio6 studi
- Oregon6 studi
- Pennsylvania9 studi
- Tennessee6 studi
- Texas11 studi
- Virginia7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT046451609-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06896188Study of ACR-2316 in Specific Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06667141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07749586Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT02886247A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT01238250First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT06993844A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05010031A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 22 Apr 2026 · NCT05683418Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Menerima pesertaStudi observasional
Usia 1 hingga 100 · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT05868629A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Menerima pesertaFase 1
Usia 18 hingga 110 · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT07064122Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jan 2026 · NCT06599619Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 24 Des 2025 · NCT06463028The Natural History of Familial Dysautonomia
Menerima pesertaStudi observasional
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 10 Nov 2025 · NCT03920774The Cancer of the Pancreas Screening-5 CAPS5)Study
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Okt 2025 · NCT02000089Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 29 Mei 2025 · NCT01793168Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.